These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 16997136)

  • 1. Leukocyte navigation mechanisms as targets in airway diseases.
    Medina-Tato DA; Watson ML; Ward SG
    Drug Discov Today; 2006 Oct; 11(19-20):866-79. PubMed ID: 16997136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylinositol 3-kinase isoforms as targets in respiratory disease.
    Marwick JA; Chung KF; Adcock IM
    Ther Adv Respir Dis; 2010 Feb; 4(1):19-34. PubMed ID: 20051446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease.
    Doukas J; Eide L; Stebbins K; Racanelli-Layton A; Dellamary L; Martin M; Dneprovskaia E; Noronha G; Soll R; Wrasidlo W; Acevedo LM; Cheresh DA
    J Pharmacol Exp Ther; 2009 Mar; 328(3):758-65. PubMed ID: 19056934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology of asthma and chronic obstructive pulmonary disease.
    Barnes PJ
    Nat Rev Immunol; 2008 Mar; 8(3):183-92. PubMed ID: 18274560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease.
    Donnelly LE; Barnes PJ
    Trends Pharmacol Sci; 2006 Oct; 27(10):546-53. PubMed ID: 16911834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic similarities and differences between asthma and chronic obstructive pulmonary disease.
    Mauad T; Dolhnikoff M
    Curr Opin Pulm Med; 2008 Jan; 14(1):31-8. PubMed ID: 18043273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells in asthma and COPD: opportunities for drug development.
    Kool M; Lambrecht BN
    Curr Opin Immunol; 2007 Dec; 19(6):701-10. PubMed ID: 17977704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease.
    Séguin RM; Ferrari N
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1505-17. PubMed ID: 19715448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease.
    Ito K; Caramori G; Adcock IM
    J Pharmacol Exp Ther; 2007 Apr; 321(1):1-8. PubMed ID: 17021257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rho kinase as a therapeutic target in the treatment of asthma and chronic obstructive pulmonary disease.
    Fernandes LB; Henry PJ; Goldie RG
    Ther Adv Respir Dis; 2007 Oct; 1(1):25-33. PubMed ID: 19124345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
    Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
    J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokines and chemokine receptors as therapeutic targets in lupus nephritis.
    Vielhauer V; Anders HJ; Schlöndorff D
    Semin Nephrol; 2007 Jan; 27(1):81-97. PubMed ID: 17336691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th2 cells as targets for therapeutic intervention in allergic bronchial asthma.
    Wegmann M
    Expert Rev Mol Diagn; 2009 Jan; 9(1):85-100. PubMed ID: 19099351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukotriene B4 enhances the activity of nuclear factor-kappaB pathway through BLT1 and BLT2 receptors in atherosclerosis.
    Sánchez-Galán E; Gómez-Hernández A; Vidal C; Martín-Ventura JL; Blanco-Colio LM; Muñoz-García B; Ortega L; Egido J; Tuñón J
    Cardiovasc Res; 2009 Jan; 81(1):216-25. PubMed ID: 18852255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases.
    Joshi BH; Hogaboam C; Dover P; Husain SR; Puri RK
    Vitam Horm; 2006; 74():479-504. PubMed ID: 17027527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-atopic intrinsic asthma and the 'family tree' of chronic respiratory disease syndromes.
    Holt PG; Sly PD
    Clin Exp Allergy; 2009 Jun; 39(6):807-11. PubMed ID: 19400902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interfering with leukocyte integrin activation--a novel concept in the development of anti-inflammatory drugs.
    Hilden TJ; Nurmi SM; Fagerholm SC; Gahmberg CG
    Ann Med; 2006; 38(7):503-11. PubMed ID: 17101541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation?
    Gwilt CR; Donnelly LE; Rogers DF
    Pharmacol Ther; 2007 Aug; 115(2):208-22. PubMed ID: 17597218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New perspectives on mechanisms underlying chronic allergic inflammation and asthma in 2007.
    Broide D
    J Allergy Clin Immunol; 2008 Sep; 122(3):475-80. PubMed ID: 18694589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels changes of blood leukocytes and intracellular signalling pathways in COPD patients with respect to smoking attitude.
    Rumora L; Milevoj L; Popović-Grle S; Barisić K; Cepelak I; Grubisić TZ
    Clin Biochem; 2008 Apr; 41(6):387-94. PubMed ID: 18206650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.